相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Origin of Renal Fibroblasts and Progression of Kidney Disease
H. Terence Cook
AMERICAN JOURNAL OF PATHOLOGY (2010)
Fate Tracing Reveals the Pericyte and Not Epithelial Origin of Myofibroblasts in Kidney Fibrosis
Benjamin D. Humphreys et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Endothelial to Mesenchymal Transition via Transforming Growth Factor-β1/Smad Activation Is Associated with Portal Venous Stenosis in Idiopathic Portal Hypertension
Azusa Kitao et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Endothelial-Myofibroblast Transition Contributes to the Early Development of Diabetic Renal Interstitial Fibrosis in Streptozotocin-Induced Diabetic Mice
Jinhua Li et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes.
Michael Mauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Restoration of Podocyte Structure and Improvement of Chronic Renal Disease in Transgenic Mice Overexpressing Renin
Anne-Cecile Huby et al.
PLOS ONE (2009)
Pericytes and Perivascular Fibroblasts Are the Primary Source of Collagen-Producing Cells in Obstructive Fibrosis of the Kidney
Shuei-Liong Lin et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Microvessel vascular smooth muscle cells contribute to collagen type I deposition through ERK1/2 MAP kinase, αvβ3-integrin, and TGF-β1 in response to ANG II and high glucose
Souad Belmadani et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Fibroblasts in Kidney Fibrosis Emerge via Endothelial-to-Mesenchymal Transition
Elisabeth M. Zeisberg et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts
Elisabeth M. Zeisberg et al.
CANCER RESEARCH (2007)
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Elisabeth M. Zeisberg et al.
NATURE MEDICINE (2007)
Renal fibrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein-7 and advanced glycation end product inhibitors
Hikaru Sugimoto et al.
DIABETES (2007)
Hepatocyte growth factor and c-Met expression in pericytes: implications for atherosclerotic plaque development
Y. Liu et al.
JOURNAL OF PATHOLOGY (2007)
The role of tubular epithelial-mesenchymal transition in progressive kidney disease
W. C. Burns et al.
CELLS TISSUES ORGANS (2007)
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
Thomas A. Wynn
JOURNAL OF CLINICAL INVESTIGATION (2007)
ECM remodeling in hypertensive heart disease
Bradford C. Berk et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Chronic NOS inhibition actuates endothelial- mesenchymal transformation
Edmond O'Riordan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
HGF gene therapy attenuates renal allograft scarring by preventing the profibrotic inflammatory-induced mechanisms
I. Herrero-Fresneda et al.
KIDNEY INTERNATIONAL (2006)
Renal and vascular hypertension-induced inflammation:: role of angiotensin II
M Ruiz-Ortega et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2006)
Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes
G Remuzzi et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Chronic hypoxia and tubulointerstitial injury: A final common pathway to end-stage renal failure
Masaomi Nangaku
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Origin of interstitial fibroblasts in an accelerated model of angiotensin II-induced renal fibrosis
JL Faulkner et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Endothelial-mesenchymal transition occurs during embryonic pulmonary artery development
E Arciniegas et al.
ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH (2005)
β-Catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse
S Liebner et al.
JOURNAL OF CELL BIOLOGY (2004)
Nitric oxide, oxidative stress, and progression of chronic renal failure
PS Modlinger et al.
SEMINARS IN NEPHROLOGY (2004)
Epithelial to mesenchymal transition in renal fibrogenesis: Pathologic significance, molecular mechanism, and therapeutic intervention
YH Liu
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Epithelial-mesenchymal transition and its implications for fibrosis
R Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats
M Adamczak et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction
JW Yang et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
BMP-7 counteracts TGF-β1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury
M Zeisberg et al.
NATURE MEDICINE (2003)
Regression of renal vascular and glomerular fibrosis: Role of angiotensin II receptor antagonism and matrix metalloproteinases
JJ Boffa et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy
JW Yang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2003)
Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models
M Zeisberg et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2003)
Obstructive nephropathy and renal fibrosis: The role of bone morphogenic protein-7 and hepatocyte growth factor
S Klahr et al.
KIDNEY INTERNATIONAL (2003)
AT(1) receptor expression in glomeruli from NO-deficient rats
S Vandermeersch et al.
NEPHRON EXPERIMENTAL NEPHROLOGY (2003)
Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation - In vitro analysis
MG Frid et al.
CIRCULATION RESEARCH (2002)
Regression of renal vascular fibrosis by endothelin receptor antagonism
JJ Boffa et al.
HYPERTENSION (2001)
The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease
S Klahr et al.
KIDNEY INTERNATIONAL (2000)
Angiotensin II activates collagen I gene through a mechanism involving the MAP/ER kinase pathway
PL Tharaux et al.
HYPERTENSION (2000)
分享论文
